BindingDB logo
myBDB logout

BDBM50044033 (S)-3-[(S)-2-((S)-2-Benzoylamino-3-1H-indol-3-yl-propionylamino)-6-(3-o-tolyl-ureido)-hexanoylamino]-N-((S)-1-carbamoyl-2-phenyl-ethyl)-N-methyl-succinamic acid::CHEMBL428103

SMILES: CN([C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCNC(=O)Nc1ccccc1C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1

InChI Key: InChIKey=CWCGENAXXREFHW-GTKRZRNESA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50044033   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cholecystokinin receptor


(Homo sapiens (Human))
BDBM50044033
PNG
((S)-3-[(S)-2-((S)-2-Benzoylamino-3-1H-indol-3-yl-p...)
Show SMILES CN([C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCNC(=O)Nc1ccccc1C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1
Show InChI InChI=1S/C46H52N8O8/c1-29-15-9-11-21-34(29)53-46(62)48-24-14-13-23-36(43(59)52-38(27-40(55)56)45(61)54(2)39(41(47)57)25-30-16-5-3-6-17-30)50-44(60)37(51-42(58)31-18-7-4-8-19-31)26-32-28-49-35-22-12-10-20-33(32)35/h3-12,15-22,28,36-39,49H,13-14,23-27H2,1-2H3,(H2,47,57)(H,50,60)(H,51,58)(H,52,59)(H,55,56)(H2,48,53,62)/t36-,37-,38-,39-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.60E+3n/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Concentration required to inhibit 50% of specific binding to Cholecystokinin type B receptor in guinea pig cortex using [125I]Bolton-Hunter CCK-8


J Med Chem 37: 309-13 (1994)


Article DOI: 10.1021/jm00028a015
BindingDB Entry DOI: 10.7270/Q2445N4S
More data for this
Ligand-Target Pair
Cholecystokinin A receptor


(Cavia porcellus)
BDBM50044033
PNG
((S)-3-[(S)-2-((S)-2-Benzoylamino-3-1H-indol-3-yl-p...)
Show SMILES CN([C@@H](Cc1ccccc1)C(N)=O)C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCNC(=O)Nc1ccccc1C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1
Show InChI InChI=1S/C46H52N8O8/c1-29-15-9-11-21-34(29)53-46(62)48-24-14-13-23-36(43(59)52-38(27-40(55)56)45(61)54(2)39(41(47)57)25-30-16-5-3-6-17-30)50-44(60)37(51-42(58)31-18-7-4-8-19-31)26-32-28-49-35-22-12-10-20-33(32)35/h3-12,15-22,28,36-39,49H,13-14,23-27H2,1-2H3,(H2,47,57)(H,50,60)(H,51,58)(H,52,59)(H,55,56)(H2,48,53,62)/t36-,37-,38-,39-/m0/s1
MMDB

Reactome pathway

UniProtKB/SwissProt

B.MOAD
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.30n/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibition of [125I]Bolton-Hunter CCK-8 binding to cholecystokinin type A receptor in guinea pig pancreas


J Med Chem 37: 309-13 (1994)


Article DOI: 10.1021/jm00028a015
BindingDB Entry DOI: 10.7270/Q2445N4S
More data for this
Ligand-Target Pair